- Home
- BRNS vs ARQQ Comparison
BRNS vs ARQQ Comparison
Compare BRNS & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRNS
- ARQQ
- Stock Information
- Founded
- BRNS 2016
- ARQQ 2017
- Country
- BRNS United Kingdom
- ARQQ United Kingdom
- Employees
- BRNS N/A
- ARQQ N/A
- Industry
- BRNS Biotechnology: Pharmaceutical Preparations
- ARQQ Computer Software: Prepackaged Software
- Sector
- BRNS Health Care
- ARQQ Technology
- Exchange
- BRNS Nasdaq
- ARQQ Nasdaq
- Market Cap
- BRNS 52.0M
- ARQQ 50.0M
- IPO Year
- BRNS 2021
- ARQQ N/A
- Fundamental
- Price
- BRNS $1.33
- ARQQ $4.31
- Analyst Decision
- BRNS Strong Buy
- ARQQ Strong Buy
- Analyst Count
- BRNS 2
- ARQQ 1
- Target Price
- BRNS $4.00
- ARQQ $50.00
- AVG Volume (30 Days)
- BRNS 17.4K
- ARQQ 101.3K
- Earning Date
- BRNS 11-07-2024
- ARQQ 11-19-2024
- Dividend Yield
- BRNS N/A
- ARQQ N/A
- EPS Growth
- BRNS N/A
- ARQQ N/A
- EPS
- BRNS N/A
- ARQQ N/A
- Revenue
- BRNS N/A
- ARQQ $740,000.00
- Revenue This Year
- BRNS $27.18
- ARQQ $341.56
- Revenue Next Year
- BRNS N/A
- ARQQ $274.91
- P/E Ratio
- BRNS N/A
- ARQQ N/A
- Revenue Growth
- BRNS N/A
- ARQQ N/A
- 52 Week Low
- BRNS $1.11
- ARQQ $3.72
- 52 Week High
- BRNS $5.10
- ARQQ $23.00
- Technical
- Relative Strength Index (RSI)
- BRNS 63.14
- ARQQ 34.60
- Support Level
- BRNS $1.15
- ARQQ $4.35
- Resistance Level
- BRNS $1.24
- ARQQ $6.00
- Average True Range (ATR)
- BRNS 0.07
- ARQQ 0.80
- MACD
- BRNS 0.01
- ARQQ -0.13
- Stochastic Oscillator
- BRNS 100.00
- ARQQ 13.87
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology which makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. Arqit delivers its symmetric key agreement technology via its QuantumCloud. Its product, QuantumCloud, enables any device to download a lightweight software agent, which can create keys in partnership with any other device. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. Key revenue comes from the UK.